KEROS THERAPEUTICS IN

58.55

27-November-24 16:45:00

15 minutes delayed

Stocks

+1.16

+2.02%

Today's range

56.78 - 58.81

ISIN

N/A

Source

NASDAQ

Keros Therapeutics Presents Results from Preclinical Studies of KER-050 and ALK2 Inhibitors at the European School of Haematology (ESH) 2nd Translational Research E-Conference

05 Mar 2021 08:00:00 By Nasdaq GlobeNewswire
Keros Therapeutics to Present at the H.C. Wainwright Global Life Sciences 2021 Virtual Conference

02 Mar 2021 08:00:02 By Nasdaq GlobeNewswire
Keros Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference

17 Feb 2021 08:00:01 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.